Cognitive Behavioral Interventions for Motivation, Psychological Distress and Quality of Life Among Individuals With Smoking Cessation: A Randomized Control Trial
CBIMPDQLISC
CBIMPDQLISC
Sponsor study identifier
interventional
60
1 country
1
Study Start
November 15, 2023
Actual (reported)Primary Completion
February 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
April 10, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The main purpose of this research is to find out how brief cognitive behavior intervention influences the motivation level, psychological distress, and quality of life among people with smoking cessation. Another objective of this research is to examine the effectiveness of cognitive behavioral therapy (CBT) among smoking people, another objective of this study is to investigate how Cognitive behavioral therapy helps to enhance the motivation level and quality of life and minimize psychological distress among people with smoking cessation
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 10, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 15, 2023
Actual (reported)December 19, 2023
Actual (reported)January 5, 2024
Actual (reported)February 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
April 10, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)
The ASSIST (Alcohol, Smoking and Substance Involvement Screening Test) was developed under the supervision of WHO (World Health Organization) by a group of researchers, clinicians, public health providers in 2010 (WHO, 2010). It mainly screens out the individual tendency to use Alcohol, Tabaco and other substances. This test mainly has seven items, which shows good test-retest reliability ranging from 0.6 to 0.8 (Humeniuk, 2008).
6 months
Cigarette Dependency scale (CDS)
The CDS (Cigarette Dependency scale) was developed by Jean-Francois Etter, PhD in 2003. (CDS; Etter et al.,2023). This scale has twelve items which gauge the addiction level, smoking compulsion, tolerability and withdrawal tendency of a person.
6 months
Depression Anxiety Stress Scale (DASS)
The (DASS) Depression Anxiety Stress Scale was developed in the University of New South Wales Australia to assess the level of depression, anxiety and stress among students. The DASS-21 was developed by Lovibond and Lovibond in 1995 (Minh Thi Hong Le, 2017). In this study the Urdu translated version of DASS was used which were translated by Naeem and Kamal in 2018 (Naeem and Kamal, 2018). It is very reliable and valid tool to assess negative emotional state of depression, stress and anxiety. The overall reliability of DASS is 0.74.
6 months
Motivation and Attitude towards changing Health (MATCH)
The MATCH (Motivation and Attitude towards changing Health) was developed by Hessler, Fisher, Polonsky, Browyer and Potter in 2018 (Hessler DM, Fisher L, Polonsky WH, Browyer V \& Potter M., 2018). It's basically consist 9 items with 5 points Likert's scale ranging from strongly disagree to strongly agree).
Experimental Group: Participants in the experimental group would receive 6-8 sessions of Psychoeducational based program Waitlist Control group: Participants in the control group would not receive a psychoeducational-based Program
Control Group: Participants in the control group didn't receive any Psychoeducational Intervention or any treatment
Psychoeducational Program would be used as an intervention strategy for individuals with smoking cessation to provide understanding and insight to the participants about the problem. Furthermore, this program would deal with interventions like motivation, cognitive conceptualization, coping skills and training, craving management, and relapse prevention among individuals with smoking cessation
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
GCUF
Faisalābad, Punjab Province, 37000, Pakistan
Qasir Abbas, PHD
Government College University Faisalabad
First Submitted
December 19, 2023
First Posted
January 5, 2024
Study Start
November 15, 2023
6 months
Primary Completion
February 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
April 10, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
January 5, 2024
Record last verified: 2024-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: